# Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports

> **Open Intelligence Dossier** · First detected: 2026-07-16 10:07 UTC · Category: Business

## Executive Summary
Eli Lilly is entering the psychedelic drug market with a deal to acquire AtaiBeckley for up to $3.8 billion to treat resistant depression.

## Intelligence Brief
Eli Lilly is moving to acquire the psychedelic biotech firm AtaiBeckley in a deal valued at up to $3.8 billion. According to reports from Reuters, Bloomberg, and Yahoo Finance, the acquisition is designed to advance therapies for mental health conditions, specifically focusing on treatment-resistant depression. The deal involves the developer of 5-MeO-DMT, as noted by Psychedelic Alpha. While some reports from CNBC and Yahoo Finance initially cited a $2.8 billion figure, other coverage, including that from Bloomberg and Reuters, indicates the total value could reach $3.8 billion. Multiple financial news outlets have highlighted the immediate market reaction to this news. Seeking Alpha reported that AtaiBeckley shares soared 66% amid buyout talks, while Barron's noted a 50% increase in the stock price.


Yahoo Finance further detailed that some venture capitalists anticipate a takeover premium of up to 105% from Eli Lilly. The Financial Times emphasized that AtaiBeckley is a psychedelic biotech firm backed by Peter Thiel. The transaction marks a significant strategic pivot for Eli Lilly as it enters the psychedelic drug race. Context provided by PR Newswire indicates that the primary goal of the acquisition is to develop and advance treatments for individuals who do not respond to traditional depression therapies. The broader industry trend involves experimental psychedelic treatments gaining traction, according to CNBC. AtaiBeckley's position as a developer of 5-MeO-DMT places it at the center of this medical shift, with the world's largest pharmaceutical company, Eli Lilly, now betting on these specific therapies to address unmet needs in mental health care.


Future developments to monitor include the finalization of the acquisition terms and the regulatory path for the 5-MeO-DMT therapies. Market watchers will likely track whether AtaiBeckley stock returns to its four-year highs, a possibility raised by Yahoo Finance. Coverage does not yet specify the exact closing date of the deal or the full list of mental health conditions beyond treatment-resistant depression that the acquired technology will target. Observers will be looking for official confirmation on the final purchase price, given the variance between the $2.8 billion and $3.8 billion figures reported across different outlets.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Reuters | Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal | [Source Link](https://news.google.com/rss/articles/CBMi2gFBVV95cUxPWVA5S0ZmbVhzc0w3UkFDUUNIbUtEYUdWVDJiNFZZRTI5YS1XRDdtVmE4bXU2ZGVJYjlieGJWdF9TS0N0QUlUUkxiMDRmVllNTGVDbEltMDlodFdUaHBmcWdPdjlIdmVvTFNmMlNLRlctc1BtcVdIdFU4LUViNFRaY0NJdU9BQlVkdktrdHl0djBwZkZaSUR2NzByYjdrNTJqZ21GMjc3R05VbFBrM2F2dW1ZWjZ1U1dHRXI4c3lENndJQXFCRGZXOVFfQlAwX3FnSmtjNG04U3V2QQ?oc=5) |
| Financial Times | Eli Lilly buys psychedelic biotech backed by Peter Thiel | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxNZEJMdW8yTXkxX2xDc1I1LXdOVUlHQ0tyMDRhcXNiQmotLUlCUGx6NzdlRm1FNVd1VWZWUFJpcjRzaXNZSVJXZ09vZDhMVjZRc1RmZmZVSkhqVXR4V3ZVRVVVRWFsVU1pWld5T3RXbFlmYXRqZGNYay1CUk5fY2REMlYwdzU?oc=5) |
| PR Newswire | Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions | [Source Link](https://news.google.com/rss/articles/CBMihgJBVV95cUxPaFBnWWZZNFc0NjRKbll6YjVJazJ4RWtueG9EVzlFc3pUdk5PTndXQmNlZTlvaWNJNmNQMXBYWkt4bzg2anRoX2J1YjRHSjVJaDFidkMwM2ZVaUZfQkFBcGtkUzVjcE9famx1ZHNGall6bnIwaG9qbnE1MC1ONU5CeTVuSzdfd19XbHd5alRhejlCOWp0NEpZakpsQkt2cEtYSzVNM2pzOG8zOEZoNmY5alhZZE04Rzh6ajU0Y1NZc285ZDlJVEVMRTNkUUN1dzIwbmctanlOY3REdV8tcXp1dUxtODEyTEs2am8zcW9uZzJHX01IUGhVRTBIcEtSVlh6ejNIRDhR?oc=5) |
| Yahoo Finance | ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxNakdtOXNhblR6NngycjZIRUk3VTNvTnFNV3NGSWtrVWJ4Z0FfOTJqOFE5eGhHWTMwV3lRNVFqYW5UNm9Zd3drc2NGWnpEZ1dPYlNRTlRQX2FGRTlaeUVheGVyX1NzYTg4bUhINHdRVlY3ZWZsR3JxS0FheG9QLVpnVkFLcExLazZxdWpOWmZYdDJkSkFiXzlPZUN5NA?oc=5) |
| CNBC | Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxPYmtnNzNheEZDZEFwLXY5UFBDc0FHeGc4OXZJUGgzeFNRVjE3RGtsOVhSMGFWRTRMNmpQdGRFZDNTWVhMcWR4MUNaOHB6X2g3LUloUE03NVZhZkxkeXFzeEV4ZnRYRWNaenBFZnAyT1BtNXNmU2NxS0VVcDU3SlZFLXFmYkRmOEZyRUdoQXltMkQyTmtLZ2tFejM1bHkxcDRmM1HSAacBQVVfeXFMUDYzb21fTEcxTXZjNWpnZ3IwT3VWclhOcXd3UkczSjdwTVozNDZ3RlpIZmxDVE5fYllfYURKT3dzLW1fWVNUdkc2M1dzUURiSHNKaEEzREljamltVDEwUVVNSG1WaUlnYVIxQzAybGF2LVJseE9nWnFYWkJnU0stZDM1Q3NiWXBhRTQtdWVLTElDaTNud09kQ2Nfa2wwaHF4UjE5SnkzNUk?oc=5) |
| Yahoo Finance | ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too? | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxOQUtqb25hRDR3OVpoYkV6OERWUDF0clE1SlBwYlVvdjI5bUlSRDlpVGVlQ2Nxc1ZqX2tUSURmbDJjbEg4dmNjTUVScDNOS2FiaWdSTHVscm9NN3J3WUpYX0VfeEpJU1hjNGl4eXljOElPNTl3X0dYcFJMdTZSOUw5dTlmZjdoNXhSLVRiXzdlSHliOHZJd3c?oc=5) |
| Psychedelic Alpha | Breaking: World’s Largest Pharmaceutical Company, Eli Lilly, Acquires 5-MeO-DMT Developer AtaiBeckley for Up to $3.8 billion | [Source Link](https://news.google.com/rss/articles/CBMi6gFBVV95cUxPYkRrMm8ybVdETmRwOVFnbktWVTJnOW5JN1BDdWtRUXNUbXdPdm1waDlPT1dmNWFzc2c0RTBaTFRNYmJyeXdZZk81VEZ3RTBFZlg4MmM4Q2c1czlHV1JNbURLNXpZUmdRaVVvd2V1dXk1UjBZWFVETzVXbnpmWjR0NW5YVk14WVh4b2FQQkNURnNaajJwdk1QYjd0THpuejVEaldBV0RGMTFpUjlPUzRtbzhXUTJuZzN6UjhPQXFlUkdUbWJncHRJWkZHZWhPYXhGdlZpUXhNRER0eWpwUTRONnJQOUJaSFhsSmc?oc=5) |
| Yahoo Finance | Eli Lilly to buy psychedelic drugmaker AtaiBeckley for up to $3.8 billion in bet on depression therapy | [Source Link](https://news.google.com/rss/articles/CBMi7gFBVV95cUxQOGQwdzgwUnlNMjVraGJpWVZMRmdxV3pIZU9KOGRBdExjUDVoNDR0aXl0Z1BlUWw5MFdxcjYwcGI4S3FsQ2tWTjE0dUs4d0ZqTzFqaVNjd0VxZUV4TjUwTUpHMmtmdDBMQ0hwY3c2YVByckpNb0RJaXY1dmxJOXBkOERSZjhvMnluMHdFbEJucjhkNUMxQTJ3amV2aWdIcGFiYmVFQ0V2amk3LV9rZldNZnh4aUVxVzliUWRYcHR4S0VlQTVNRE9XTjBDTlg0Q0VCUklUVDZCTEVYTC1lWnN1Nk9XSDFJbE5CRG0wZFF3?oc=5) |
| Bloomberg.com | Lilly to Buy Psychedelic Firm AtaiBeckley for Up to $3.8 Billion | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxNdldiRTNWVWdoTkJ5dW5RZldrV3JPZHo4Wm04OGVha0tWQktLcVd6NUVNanViOXp2TVN6ZkV1NWJlNmZHNEpSSGl0QmpORW10VkZxTjV0Z1VvdDZkQVhwLXNCMU40c2hIa2hOZFlRcmV4bGdNVFBBQ2lGa1BsT2g1MUpBb2EzaTh5TmVCT1IwYVF4X3hWSWZ2WkF0NlBUUlZGd3N2QWxSajhWRTZCelRpbU10Smo?oc=5) |
| Bloomberg.com | Lilly Said to Near Deal for Psychedelic Drugmaker AtaiBeckley | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxNd1NEbmhORl9JUHljTHlqdHRhbGl0MUNfM3k3b0ZSbThGekZ5TTlvN1k2dVZvY3JncnlEQ0UyWVJIQUN5eVNmRUZFTHhJSEE1a2Q4enRzeVBlNmhfS2h3bmtSRDk3eE5FVXdGdXcwQ3hSd2g0cE1ZYVl6Mkwydm5ycXA0NGJwcV9TQi1Sd1RNNHgwRWZGRk1VZGY3V0JheEpWWkQ0YkRENGFveTFMc1Uwb1dB?oc=5) |
| Seeking Alpha | Psychedelic drugmaker AtaiBeckley shares soar 66% on Eli Lilly buyout talks (LLY:NYSE) | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxQSDFGTThvdFhxb2JLQkhkNndtR3piU1NMRkFTdE5DN211QllZbGR6M2JPZ1pKRm45Qld0a3pCaWc2MGo3dzdLNDNZT2dfLVVVWHVHdkVQMlJfeUZLcHpxX0tqTDBTcE9RcV8yTlRZS0NVem9oMDJGSlRUWV82Q252b3VwTHdYSGt0UDJnM05SRmhiZ280UUJaeVdNV2VEMWtUR1VGSFdyM2dISDBOUlBwZnpn?oc=5) |
| Barron's | This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxQMmlNS2lVdDVXSlRHYXF5NW1tU1BwQndxYWwzSGthSFdmckV1aU5rdnVFT0FzUXpVSUNzLU95OEpEOGNjYTVvelZmY3dib2NCZlp0RnpUUzc5ZG92NlM2Nm9QaGo4VlVFeW90Y0l6ZU1PNWlNOWx0dG9lQ1lJS1c1QXdqZXJIa0U?oc=5) |
| Yahoo Finance | Here Is Why AtaiBeckley (ATAI) Is One Of The 10 Best Stocks Under $10 That Could Triple | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxPUWRPWm9BSGVHOTUyQ1VzM0VNcTUwSWhaemFzeWJuY1p1TGFnVGRxZXcwYS1mVFFJWmowRVVVTjBBMnM2X0t6R295RmdVaVZ3d20wTUhrYmE1WFJlSmplMDB4VGVYbUt2Sm95NEFIOWFXREdLZ2Ezd3dYRXRjMGRoejV1M3NwRVN3Vk1JWExBSGtlR3RoUFVv?oc=5) |
| Reuters | Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports | [Source Link](https://news.google.com/rss/articles/CBMi3gFBVV95cUxQUkdBem1IX3AtekZzbllhUEZyTU9HQU1RY1AxRF9ZSnNoNlAybXNmcnFnTDZ3X3RJWDQ4bXNlNERLeWlUNy02dFNfQl9BbXBKZmRHVXRpdi1oMXltUF9qNVB2NEQ0WDJJbmdXSDJ6WGJDUzR2c0t6MDVycnhKOWRCckwySkc1SjN6d1FZNWpzZW5nSnRHRWl4M3dtaXNMeGN1d0RuMVJsTjR1R25EYWhsbmR5Rk9ndzdhTzJuVzN4QUg2SFR5cDZPbUxDVHhjVmhWaDlaTGI0Z1NwTUhGTlE?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-16/eli-lilly-nears-deal-to-buy-psychedelic-drugmaker-ataibeckley-bloomberg-news*